Literature DB >> 28259385

KSHV microRNAs: Tricks of the Devil.

Jie Qin1, Wan Li1, Shou-Jiang Gao2, Chun Lu3.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of Kaposi's sarcoma (KS), a vascular tumor frequently found in immunodeficient individuals. KSHV encodes 12 pre-microRNAs (pre-miRNAs), which are processed into 25 mature microRNAs (miRNAs). KSHV miRNAs maintain KSHV latency, enhance angiogenesis and dissemination of the infected cells, and interfere with the host immune system by regulating viral and cellular gene expression, ultimately contributing to KS development. In this review, we briefly introduce the biogenesis of miRNAs and then describe the recent advances in defining the roles and mechanisms of action of KSHV miRNAs in KS development.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; KSHV microRNA; Tumor dissemination; Viral latency

Mesh：

Substances：

Year:  2017        PMID： 28259385      PMCID： PMC6904892          DOI： 10.1016/j.tim.2017.02.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  87 in total

1.  Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus.

Authors:  Mark A Samols; Jianhong Hu; Rebecca L Skalsky; Rolf Renne
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  High conservation of Kaposi sarcoma--associated herpesvirus microRNAs implies important function.

Authors:  Christopher S Sullivan
Journal:  J Infect Dis       Date:  2007-01-23       Impact factor: 5.226

3.  Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155.

Authors:  Rebecca L Skalsky; Mark A Samols; Karlie B Plaisance; Isaac W Boss; Alberto Riva; M Cecilia Lopez; Henry V Baker; Rolf Renne
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

4.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

5.  The expression profiles of microRNAs in Kaposi's sarcoma.

Authors:  Xiu-Juan Wu; Xiong-Ming Pu; Zong-Feng Zhao; Ya-Nan Zhao; Xiao-Jing Kang; Wei-Dong Wu; Yun-Min Zou; Cao-Ying Wu; Yuan-Yuan Qu; De-Zhi Zhang; Yan-Yan Feng; Jian-Yong Liu
Journal:  Tumour Biol       Date:  2014-10-01

6.  Potent effect of target structure on microRNA function.

Authors:  Dang Long; Rosalind Lee; Peter Williams; Chi Yu Chan; Victor Ambros; Ye Ding
Journal:  Nat Struct Mol Biol       Date:  2007-04-01       Impact factor: 15.369

7.  Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.

Authors:  Johanna R Abend; Dhivya Ramalingam; Philippe Kieffer-Kwon; Thomas S Uldrick; Robert Yarchoan; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

8.  A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.

Authors:  Xiufen Lei; Ying Zhu; Tiffany Jones; Zhiqiang Bai; Yufei Huang; Shou-Jiang Gao
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

9.  Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs.

Authors:  Joseph M Ziegelbauer; Christopher S Sullivan; Don Ganem
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

10.  Distance constraints between microRNA target sites dictate efficacy and cooperativity.

Authors:  Pål Saetrom; Bret S E Heale; Ola Snøve; Lars Aagaard; Jessica Alluin; John J Rossi
Journal:  Nucleic Acids Res       Date:  2007-03-27       Impact factor: 16.971
View more
  28 in total

Review 1.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  Kaposi Sarcoma-Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation.

Authors:  Lu Dai; Jing Qiao; Jun Yin; Alana Goldstein; Hui-Yi Lin; Steven R Post; Zhiqiang Qin
Journal:  J Infect Dis       Date:  2020-03-28       Impact factor: 5.226

3.  Cis regulation within a cluster of viral microRNAs.

Authors:  Monika Vilimova; Maud Contrant; Ramy Randrianjafy; Philippe Dumas; Endrit Elbasani; Päivi M Ojala; Sébastien Pfeffer; Aurélie Fender
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

4.  Specific Inhibition of Viral MicroRNAs by Carbon Dots-Mediated Delivery of Locked Nucleic Acids for Therapy of Virus-Induced Cancer.

Authors:  Enguo Ju; Tingting Li; Zhen Liu; Suzane Ramos da Silva; Shan Wei; Xinquan Zhang; Xian Wang; Shou-Jiang Gao
Journal:  ACS Nano       Date:  2020-01-08       Impact factor: 15.881

Review 5.  Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses.

Authors:  Takanobu Tagawa; Anna Serquiña; Insun Kook; Joseph Ziegelbauer
Journal:  Semin Cell Dev Biol       Date:  2020-07-03       Impact factor: 7.727

6.  Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.

Authors:  Soo Mi Lee; Kenneth M Kaye; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 11.205

7.  A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.

Authors:  W Li; M Hu; C Wang; H Lu; F Chen; J Xu; Y Shang; F Wang; J Qin; Q Yan; B J Krueger; R Renne; S-J Gao; C Lu
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

8.  CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhipin Liang; Zhiqiang Qin; Adam I Riker; Yaguang Xi
Journal:  Biochem Biophys Res Commun       Date:  2020-10-19       Impact factor: 3.575

9.  miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1).

Authors:  Hosni A M Hussein; Shaw M Akula
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

Review 10.  Role of Pattern Recognition Receptors in KSHV Infection.

Authors:  Timsy Uppal; Roni Sarkar; Ranjit Dhelaria; Subhash C Verma
Journal:  Cancers (Basel)       Date:  2018-03-20       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.